Amphastar P Stock Today
| AMPH Stock | USD 44.09 0.47 1.08% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Amphastar is trading at 44.09 as of the 21st of November 2024. This is a 1.08% increase since the beginning of the trading day. The stock's open price was 43.62. Amphastar has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Amphastar P are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 2014 | Category Healthcare | Classification Health Care |
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. The company has 48.08 M outstanding shares of which 4.34 M shares are presently shorted by private and institutional investors with about 15.91 trading days to cover. More on Amphastar P
Moving against Amphastar Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Amphastar Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Old Name | Aggregated Micro Power Hldg | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation | |||||
Debt LevelsAmphastar can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Amphastar's financial leverage. It provides some insight into what part of Amphastar's total assets is financed by creditors.
| |||||
Amphastar P (AMPH) is traded on NASDAQ Exchange in USA. It is located in 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 and employs 1,761 people. Amphastar is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.12 B. Amphastar P conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 48.08 M outstanding shares of which 4.34 M shares are presently shorted by private and institutional investors with about 15.91 trading days to cover.
Amphastar P currently holds about 183.39 M in cash with 183.5 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.74.
Check Amphastar Probability Of Bankruptcy
Ownership AllocationAmphastar holds a total of 48.08 Million outstanding shares. The majority of Amphastar P outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amphastar P to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amphastar. Please pay attention to any change in the institutional holdings of Amphastar P as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amphastar Ownership Details
Amphastar Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Millennium Management Llc | 2024-06-30 | 738.7 K | |
| American Century Companies Inc | 2024-09-30 | 639.6 K | |
| T. Rowe Price Associates, Inc. | 2024-06-30 | 583.9 K | |
| Northern Trust Corp | 2024-09-30 | 583.4 K | |
| Btim Corp | 2024-09-30 | 539.6 K | |
| Renaissance Technologies Corp | 2024-09-30 | 489.4 K | |
| Bessemer Group Inc | 2024-06-30 | 466.2 K | |
| Amvescap Plc. | 2024-06-30 | 450.9 K | |
| Mesirow Institutional Investment Management, Inc. | 2024-09-30 | 413.9 K | |
| Blackrock Inc | 2024-06-30 | 5.9 M | |
| Vanguard Group Inc | 2024-09-30 | 2.7 M |
Amphastar Historical Income Statement
Amphastar Stock Against Markets
Amphastar Corporate Management
| Ziping Luo | Chief Chairman | Profile | |
| Peter Langosh | VP Audit | Profile | |
| MBA MPH | Executive Operations | Profile | |
| MP MBA | Senior Operations | Profile | |
| Rong MS | Senior Production | Profile | |
| Dan MBA | Senior Communication | Profile |
Already Invested in Amphastar P?
The danger of trading Amphastar P is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amphastar is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amphastar. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amphastar P is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amphastar P. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Earnings Share 3.01 | Revenue Per Share 14.942 | Quarterly Revenue Growth 0.059 | Return On Assets 0.0867 |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.